| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.16 | 0.7 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.1 | 0.7 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |